However, the biochemical events underlying these processes have not been studied yet and it is therefore important to investigate whether the activity of the Tim-3-galectin-9 secretory pathway is specific solely to AML cells or whether it is also common for breast and other solid tumors. Here, HAVCR2 is linked to acute myeloid leukemia.